Line 2: |
Line 2: |
| | | |
| ====Description==== | | ====Description==== |
| + | |
| + | Equine protozoal myeloencephalitis |
| + | Equine protozoal myeloencephalitis is caused by the protozoan |
| + | Sarcocystis neurona and has only been seen in the |
| + | UK in horses imported from the Americas. S neurona produces |
| + | signs relating to diffuse, focal and multifocal lesions |
| + | of the white and grey matter of the spinal cord and brain. |
| + | Horses may present with ataxia or paresis of one or more |
| + | limbs, manifest as stumbling, falling, knuckling and toe |
| + | dragging. Sacrococcygeal involvement can result in signs |
| + | of involvement of the cauda equina, thus mimicking |
| + | polyneuritis equi. In addition, signs relating to involvement |
| + | of the cranial nerves may be evident, producing signs such |
| + | as loss of tongue tone, loss of sensation to the face and unilateral |
| + | facial paralysis. With brain involvement, dysphagia, |
| + | circling, head tilt or recumbency may be noted. |
| + | At present, diagnosis is based on clinical signs and a |
| + | previous history of importation from the Americas. With |
| + | the recent isolation of the causative organism, laboratory |
| + | diagnostic tests on serum and spinal fluid will become |
| + | available in the future. Treatment involves the administration |
| + | of trimethoprim/sulphadiazine (15 mg/kg orally |
| + | twice daily) in combination with pyrimethamine (0-25 |
| + | mg/kg orally once daily), both for at least six weeks. The |
| + | prognosis is dependent on the severity and duration of |
| + | neurological signs.(EPM 3) |
| | | |
| EQUINE protozoal myeloencephalitis (EPM) is a progressive | | EQUINE protozoal myeloencephalitis (EPM) is a progressive |